DIA 2016 Annual Meeting

I am leading the global team here at SOUSEIKAI.My background is in neuropharmacology, but now I feel privileged witnessing and being part of the process of developing new and innovative treatments against human diseases in all therapeutic areas.It would be great to learn more about... Read More →

Dr. Comfort is Associate Director for Risk Management and Sr. Safety Science Leader for Roche-GNE Late Stage Ophthalmology/Hematology Products. He is a Board Certified Neurologist with 13 years combined industry experience including roles as former Medical Reviewer at the US FDA and... Read More →

Over 17 years of experience in the pharmaceutical industry with more than 14 years in regulatory affairs working across multiple therapeutic areas. Colleen has held Regulatory Affairs positions at Sanofi-Aventis, GlaxoSmithKline, and Accenture and is currently the Executive Director... Read More →

Her wide-ranging experience is underscored by numerous scientific publications, including academic and peer-reviewed journal articles; video, oral, and poster presentations; awards and grants including Cook Medical Don Wilson Award by the American Society for Gastrointestinal Endoscopy... Read More →

Joe Fiore is Sr. Clinical Scientist at Merck & Co., Inc. in Upper Gwynedd, PA within the Clinical Sciences & Study Management group. He supports oncology clinical trials across phase I-III for the anti-PD1 drug pembrolizumab for patients with non-small cell lung cancer and advanced... Read More →

US operations lead and co-founder at Algorics, a data analytics software and solutions company in the clinical trials space. Nick has been working in the application of software technology in clinical trials since 1998. He has previously held leadership positions with global responsibilities... Read More →

Rick has 25 years experience in global technology solutions. Rick leads the effort in the development of ISIDOR®, a transformational and scalable informatics platform which integrates research and sample data to advance bioscience discoveries._x000D_ _x000D_ Rick received his BS... Read More →

Michelle has been working in the drug and device development industry for 30 years. She has enjoyed a variety of positions that allowed her to create product development plans, run study operations, and support product commercialization objectives. Michelle presently serves Parexel... Read More →

Seasoned pharmaceutical and diagnostics executive with experience leading cross-functional teams focused on drug development, clinical operations, business development and commercialization. Known for combining strong general management expertise, effective strategic thinking skills... Read More →

Elisa Holzbaur is Manager, ePRO Services for Almac Clinical Technologies. In this role, she is responsible for creating and maintaining operational procedures to support the delivery of Almac’s ePRO solutions. Working with functional teams across the organization, Elisa provides... Read More →

I was trained from Johns Hopkins Bloomberg School of Public Health with 26 years of experience in Clinical Trials. My vision is to build the bridge between global CROs and the Key opinion leaders (KOI) so that Bangladesh becomes a potential game changer for international clinical... Read More →

Dr Liberti has worked in pharmaceutical regulatory affairs, communications and clinical R&D for the past four decades. Since 2009 he has served as the Executive Director of CIRS (the Centre for Innovation in Regulatory Science, Ltd, forming part of Clarivate Analytics). He has been... Read More →

Xiu Wei is the Head of Innovation in Quintiles APAC. She leads the idealization, development & execution of mobile initiatives focusing on leveraging mobile technology to increase productivity & quality in Clinical Operations across APAC. Her team also collaborates with Quintiles... Read More →

Richard Macaulay, PhD, is a senior director with Parexel® Access in London. Richard has specialized for ten years in regulatory and market access strategy, in particular helping obtain regulatory and payer approval for treatments lacking Phase III trial data, with particular expertise... Read More →

Samarth Parikh is the Post-Doctoral Fellow at Janssen Pharmaceutical Companies of Johnson & Johnson in Global Medical Safety. He is responsible for project managing and preparing safety surveillance reports/responses to internal and external safety queries. In addition, he is also... Read More →

Matt Pazdernik is the Submission Planning & Portfolio Management Lead for Merck Regulatory Affairs, responsible for the global enterprise system to manage Regulatory Submission Plans, an enterprise-level Portfolio Planning & Project Management capability integrating the process and... Read More →

Jennifer Ross is Lead Biostatistician at Almac, where she provides statistical consultancy on randomization methodology, IXRS® implementation and ePRO implementation. She is a member of C-Path’s ePRO Consortium where she is co-Chair of the Publications and Presentations Subcommittee... Read More →

I have 10 years of industry experience, starting as a clinical research coordinator and moving to site management and business development oversight for a large mutlispecialty research site in Raleigh, NC that focused on adult and pediatric phase Ib-IV clinical trials. For the past... Read More →

I have 10 years of industry experience, starting as a clinical research coordinator and moving to site management and business development oversight for a large mutlispecialty research site in Raleigh, NC that focused on adult and pediatric phase Ib-IV clinical trials. For the past... Read More →

Dr. Shah is a Regulatory Affairs professional with over 18 years of experience ranging from basic research through product development. Dr. Shah's experience as the Regulatory lead is varied and includes clinical trials for drugs and biologics in various therapeutic areas from diabetes... Read More →

Ms. Stella Stergiopoulos leads multi-sponsored research projects at Tufts CSDD. She has experience conducting research on pharmaceutical industry practices and trends affecting pharmacovigilance, non-clinical drug development, pharmaceutical outsourcing practices, cycle time metrics... Read More →

Mrs. (Holbrook) Thompson has been working in quality assurance for over 15 years and joined FDA Quality and Regulatory Consulting (FDAQRC) in 2015. She completed her Bachelors of Science at North Carolina State University. Mrs. Thompson has been a Registered Quality Assurance Professional... Read More →

Chris has a PhD in Behavioural Neuropharmacology and is an experienced product strategist with over 19 years’ experience in the delivery of innovative business and consumer solutions. Chris’ career started in the financial services and for the last 10 years, Chris has been translating... Read More →